Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599336 · ClinicalTrials.gov registry record · NA
RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03599336: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03599336 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03599336, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
There is currently no consensus amongst orthopedic specialists on the best way to treat 3- and 4-part proximal humerus fractures. No surgery and surgery with a type of shoulder replacement called a reverse total shoulder arthroplasty are two options that many orthopedists use. This study is being performed to evaluate the differences in short- and long-term pain and functional outcomes between patients who are treated with these two different options.
Primary Outcome
The American Shoulder and Elbow Surgeons (ASES) score is a well-validated, patient-reported outcome measure used by shoulder and elbow surgeons. The score ranges from 0-100 with 100 signifying the best outcome. Half of the score correlates to pain and half to function, both on a 0-50 scale where higher is again considered a better outcome. The pain portion is tabulated by taking the patient's response on a visual analogue scale (0 to 10 scale where 0 represent no pain and 10 represents worst pai
Interventions
- PROCEDURE Reverse Total Shoulder Arthroplasty (rTSA)
- OTHER Nonoperative Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2020-10-29 |
| Phase | NA |
Why NCT03599336 stopped before completion
NCT03599336 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Reverse Total Shoulder Arthroplasty (rTSA) is the first listed.
NCT03599336 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03599336 about?
NCT03599336 is a clinical study titled "RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures". There is currently no consensus amongst orthopedic specialists on the best way to treat 3- and 4-part proximal humerus fractures. No surgery and surgery with a type of shoulder replacement called a reverse total shoulder arthroplasty are two options that many orthopedists use. This study is being pe...
What is the current status of trial NCT03599336?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-08-01. Estimated completion is 2020-10-29.
What interventions are being tested in trial NCT03599336?
The interventions under investigation include: Reverse Total Shoulder Arthroplasty (rTSA) (PROCEDURE), Nonoperative Treatment (OTHER).
Who is sponsoring clinical trial NCT03599336?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03599336's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI